Literature DB >> 19544370

Imaging pharmaceutical tablets with optical coherence tomography.

Jakob M A Mauritz1, Richard S Morrisby, Roger S Hutton, Coulton H Legge, Clemens F Kaminski.   

Abstract

Optical coherence tomography (OCT) is a recently developed optical technique that produces depth profiles of three-dimensional objects. It is a nondestructive interferometric method responding to refractive index variation in the sample under study and can reach a penetration depth of a few millimetres. OCT employs near-infrared (NIR) light and therefore provides a link between NIR spectroscopy and Terahertz (THz) measurements that are often used to characterise tablets. In this article we assess the potential of OCT as a reliable and practical tool in the analysis of pharmaceutical tablets and coatings. A variety of tablets were tested with different shapes, formulations and coatings. We consider the origins of contrast in the obtained images and demonstrate that it correlates strongly with the expected tablet structure. The influence of absorption and scattering are considered for the wavelength ranges used. The results show that OCT is a promising diagnostic tool with an important role to play in the tablet and coating technologies. The high measurement speed of OCT and its relative ease of implementation make it also an attractive candidate technology for in-line quality control during manufacturing.

Mesh:

Substances:

Year:  2010        PMID: 19544370     DOI: 10.1002/jps.21844

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Validating a Numerical Simulation of the ConsiGma(R) Coater.

Authors:  Peter Boehling; Dalibor Jacevic; Frederik Detobel; James Holman; Laura Wareham; Matthew Metzger; Johannes G Khinast
Journal:  AAPS PharmSciTech       Date:  2020-11-26       Impact factor: 3.246

2.  Quantifying Pharmaceutical Film Coating with Optical Coherence Tomography and Terahertz Pulsed Imaging: An Evaluation.

Authors:  Hungyen Lin; Yue Dong; Yaochun Shen; J Axel Zeitler
Journal:  J Pharm Sci       Date:  2015-06-17       Impact factor: 3.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.